The company stated that no generic versions of semaglutide are currently available and described compounded alternatives as "unapproved fake or illegitimate knockoffs" that could "expose patients to serious safety and efficacy risks." As part of their effort to address this issue, Novo Nordisk has advocated for semaglutide to be added to the FDAs list of drugs that present "demonstrable difficulties for compounding." FDAs Decision and Timelines In February, the FDA declared that the semaglutide shortage was officially over
This article examines how GLP-1 medications influence bowel function and provides practical guidance for managing digestive symptoms
Tricking the body into feeling full Neuroscientist Tim Moran wasnt involved in the VIBES study
And tirzepatide, the GLP-1/GIP dual receptor agonist you were considering for weight loss or blood sugar management , carries an FDA boxed warning about thyroid tumors
29.95 Prices may be subject to local taxes which are calculated during checkout Similar content being viewed by others Subjects Change history 28 May 2025 A Correction to this paper has been published: References Drucker, D
It should feel coached, manageable, and adjustable - and it should leave you feeling like you can come back